NPM1 and myelodysplastic syndrome: This is a very strange situation—not to say that this ambiguity of diagnoses indicates that there is something profoundly wrong with the acceptance of two concurrent classification systems—because the patient in question clearly has a single disease, which cannot simultaneously be classified as both AML with mutated NPM1 and MDS, not otherwise specified (NOS).